Products for Research Use Only
RegisterLogin

PCSK9-IN-10

CAT: 1410-M36396-01Size: 2 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M36396-01Size:2 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
PCSK9-IN-10, a potent and orally active inhibitor of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), exhibits a half-maximal inhibitory concentration (IC50) of 6.4 µM. By enhancing the expression of Low-Density Lipoprotein Receptor (LDLR) protein and reducing PCSK9 expression, PCSK9-IN-10 effectively decreases atherosclerosis progression. This compound holds promise for hyperlipidemia research applications.
CAS Number
368434-98-4
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
373.41
Molecular Formula
C18H23N5O4
Notes
Research use only, not for human use.
Receptor
Serine/threonin kinase

Related Products

CatalogName
M17488-01LM22B-10
M16632-0110-NCP
M10550-01Aurora A-IN-10
M29578-01Dolastatin 10
M28938-01FLT3-IN-10
M27632-01GSA-10
M26101-01CDK9-IN-10
M22749-01MitoBloCK-10
M19824-0110-Hydroxycampothecin
M12918-01PI4KIIIbeta-IN-10

Alternative Products

CatalogName
BA8064-10PCSK9-IN-10
pro-2043PCSK9
048564PCSK9 (Boehringer PCSK9) discontinued
048566PCSK9 (Schering patent PCSK9) discontinued
C00552-1mgAnti-PCSK9 (Boehringer anti-PCSK9)
048565PCSK9 (Merck patent PCSK9) discontinued

Popular Products